Samuel J. Reich, CEO of SAB Biotherapeutics SABS, has filed 1 purchase and 0 sales on the open market. The latest trade was on 02/03.

SR

SR

Samuel J. Reich

CEO

Company

SAB Biotherapeutics SABS

First filing

23/03/02

Trades

8 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

02/03

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
SAB BiotherapeuticsSABS	Open-market buy	23/11/29	23/11/30	11,000 sh	$0.89	$9,790	+5.3%